Neuroprotective compositions and methods
View Patent ↗Neurite outgrowth-promoting prostaglandins (NEPPs) and other electrophilic compounds bind to Keap1, a negative regulator of the transcription factor Nrf2, and prevent Keap1-mediated inactivation of Nrf2 and, thus, enhance Nrf2 translocation into the nucleus of neuronal cells. Therefore, neuroprotective compositions and related methods are provided that employ such neuroprotective compounds, and prodrugs of such compounds, to cause dissociation of Nrf2 from a Keap1/Nrf2 complex.
1. A compound, or pharmaceutically acceptable salt thereof, of Formula IV:
wherein:
X 21 , X 22 , X 23 , X 24 , X 25 , and X 27 are each independently H, OH, oxo, or Y;
wherein for oxo: one of X 21 and X 25 ; X 22 ; X 23 ; or X 24 and X 27 taken together can independently be oxo;
Y is B-C-D or C-B-D or C-B-C-D, any of which may be attached to a ring carbon to form a fused ring;
B is selected from the group consisting of null, carbonyl, carboxy, ether, sulfanyl, amino, —NHC(O)— and —C(O)NH—, any of which is optionally substituted;
C is selected from the group consisting of null, alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, arylalkyl, and arylalkenyl, any of which is optionally substituted, and which may be attached to a ring carbon so as to form a fused ring; and
D is selected from the group consisting of null, carboxy, benzoic acid, hydroxybenzoic acid, SO 3 H, PO 3 , NO 3 , NO 2 , NO, amino, hydroxyl;
wherein X 26 is carboxy or carboxy-terminated group;
wherein B, C and X 26 are optionally substituted with one or more substituents independently selected from lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower heteroalkyl, lower heterocycloalkyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower perhaloalkyl, lower perhaloalkoxy, lower cycloalkyl, phenyl, aryl, aryloxy, lower alkoxy, lower haloalkoxy, oxo, lower acyloxy, carbonyl, carboxyl, lower alkylcarbonyl, lower carboxyester, lower carboxamido, cyano, hydrogen, halogen, hydroxy, amino, lower alkylamino, arylamino, amido, nitro, thiol, lower alkylthio, arylthio, lower alkylsulfinyl, lower alkylsulfonyl, arylsulfinyl, arylsulfonyl, arylthio, sulfonate, sulfonic acid, trisubstituted silyl, —N3, —SH, —SCH3, —C(O)CH3, —CO2CH3, —CO2H, pyridinyl, thiophene, furanyl, lower carbamate, and lower urea.
2. The compound of claim 1 wherein B is null.
3. The compound of claim 1 wherein X 21 and X 24 are each independently methyl, carboxy, —C(O)OCH 3 , CH 2 OH, or CH 2 OC(O)CH 3 .
4. The compound of claim 1 wherein X 22 and X 23 are each independently H, OH, oxo, or —OCH 3 .
5. The compound of claim 1 wherein X 25 or X 27 or both are methyl.
6. The compound of claim 1 wherein at least one of X 21 or X 27 is carboxy.
7. The compound of claim 1 wherein one of X 21 or X 24 is CH 3 and the other is selected from the group consisting of carboxy, —C(O)OCH 3 , —CH 2 OH, and —CH 2 OC(O)CH 3 .
8. The compound of claim 7 wherein at least one of X 22 and X 23 is hydroxy or oxo.
9. The compound of claim 1 wherein the carbon to which X 26 is attached has R configuration.
10. A pharmaceutical composition comprising:
(a) a compound of claim 1 ; and (b) a pharmaceutically acceptable carrier.
11. Para-carnosic acid.